In The News Mexico files 2nd lawsuit against arms dealers in US MEXICO CITY (AP)(October 10, 2022) — The Mexican government filed another U.S. gun lawsuit Monday,…Nick ShadowenOctober 13, 2022
In The News U.S. States, Cities, and Experts Back Mexico’s Lawsuit Against Gunmakers More than a dozen state attorneys general and a spread of activists, researchers, and district…Nick ShadowenFebruary 2, 2022
Antitrust Pharma Giants’ $454M Glumetza Antitrust Deal Gets Initial OK By Hannah Albarazi, Law360, San Francisco (September 22, 2021, 5:04 PM EDT) U.S. District Judge William…Nick ShadowenSeptember 23, 2021
Antitrust Lupin agrees to pay $150 mln to settle Glumetza antitrust claims by Black Brittain (Reuters) - Indian generic drugmaker Lupin Pharmaceuticals Inc has agreed to pay…Nick ShadowenSeptember 22, 2021
Antitrust Bausch to pay $300 mln in antitrust suit over diabetes drug By Brendan Pierson Sept 9 (Reuters) - Bausch Health Companies Inc (BHC.TO) has agreed to pay $300 million…Nick ShadowenSeptember 10, 2021
In The News Mexico is suing US gunmakers for thousands of guns trafficked across the border each year. Can they win? by Karol Suarez and Danielle Renwick, CNN Mexico City (CNN) When early in his term,…Nick ShadowenAugust 30, 2021
Antitrust Takeda Can’t Duck Generic-Drug Delay Suit at 2nd Circ. By Bryan Koenig, Law 360, August 25, 2021 The Second Circuit found on Wednesday that…Nick ShadowenAugust 27, 2021
Civil Rights Texas-Based Litigator Helps Mexico Take on the Gun Industry Last week, the Mexican government sued more than a half-dozen gun manufacturers in a Boston…Nick ShadowenAugust 10, 2021
Antitrust Bausch, Assertio, Lupin must face antitrust claims over diabetes drug Glumetza Bausch Health Cos Inc, Assertio Therapeutics Inc and Lupin Pharmaceuticals Inc must face claims by…Nick ShadowenMay 14, 2021
Antitrust 2nd Circ. Questions Takeda’s ‘Lazarus’ Take On Drug Patents Law360 (April 7, 2021, 6:53 PM EDT) -- A Second Circuit panel grilled Takeda in…Nick ShadowenApril 14, 2021